A small-molecule carrier for the intracellular delivery of a membrane-impermeable protein with retained bioactivity

Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2407515121. doi: 10.1073/pnas.2407515121. Epub 2024 Oct 22.

Abstract

Intracellular protein delivery has the potential to revolutionize cell-biological research and medicinal therapy, with broad applications in bioimaging, disease treatment, and genome editing. Herein, we demonstrate successful delivery of a functional protein, cytochrome c (CYC), by using a boron cluster anion as molecular carrier of the superchaotropic anion type (B12Br11OPr2-). CYC was delivered into lipid bilayer vesicles as well as living cells, with a cellular uptake ratio approaching 90%. Mechanistic studies showed that CYC was internalized into cells through a permeation pathway directly into the cytoplasm, bypassing endosomal entrapment. Upon carrier-assisted internalization, CYC retained its bioactivity, as reflected by an induced cell apoptosis rate of 25% at low dose (1 µM). This study furbishes a direct protein delivery method by a molecular carrier with high efficiency, confirming the potential of inorganic cluster ions as protein transport vehicles with an extensive range of future cell-biological or biomedical applications.

Keywords: boron clusters; chaotropic effect; cytochrome C; lipid bilayer permeation; protein delivery.

MeSH terms

  • Apoptosis / drug effects
  • Cytochromes c* / metabolism
  • Drug Carriers / chemistry
  • HeLa Cells
  • Humans
  • Lipid Bilayers / metabolism

Substances

  • Cytochromes c
  • Lipid Bilayers
  • Drug Carriers